(S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes

Antiviral Research

Volumn 35, Issue 1, 1997, Pages 23-27

  Srinivas, Ranga V ^a   Connely, Michele ^a   Fridland, Arnold ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Epithelial cell; HIV 1; T lymphocyte

Indexed keywords

ADEFOVIR; CIDOFOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LEVEL; CELL LINE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; EPITHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLITE; PHOSPHORYLATION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ADENINE; ANTI-HIV AGENTS; ANTIGENS, CD4; ANTIVIRAL AGENTS; CELL LINE; CYTOSINE; GENETIC ENGINEERING; HELA CELLS; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PHOSPHORYLATION; T-LYMPHOCYTES; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030988373     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)01035-8     Document Type: Article

References (19)

1. Aduma, P., Connelly, M.C., Srinivas, R.V. and Fridland, A. (1995) Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates. Mol. Pharmacol. 47, 816-822.
2. Balzarini, J. (1994) Anti-retroviral and pharmacological properties of 9-(2-phosphonylmethoxyethyl) adenine (PMEA). Adv. Exp. Med. Biol. 370, 459-464.
3. Bronson, J.J., Ferrara, L.M., Hitchcock, M.J., Ho, H.T., Woods, K.L., Ghazzouli, I., Kern, E.R., Soike, K.F. and Martin, J.C. (1990) (S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine (HPMPC): a potent antiherpesvirus agent. Adv. Exp. Med. Biol. 278, 277-283.
4. Connelly, M.C., Robbins, B.L. and Fridland, A. (1993) Mechanism of uptake of the phosphonate analog (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in Vero cells. Biochem. Pharmacol. 46, 1053-1057.
5. De Clercq, E. (1993).Therapeutic potential of HPMPC as an antiviral drug. Rev. Med. Virol. 3, 85-96.
6. Foster, S.A., Cerny J. and Cheng, Y-C. (1991). Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phophonylmethoxyethyl)adenine. J. Biol. Chem. 266, 238-244.
7. Gong, Y.F., Marshall, D.R., Srinivas, R.V. and Fridland, A. (1994) Susceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonates. Antimicrob. Agents Chemother. 38, 1683-1687.
8. Gong, Y.F., Srinivas, R.V. and Fridland, A. (1993) 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2′, 3′-dideoxyinosine. Mol. Pharmacol. 44, 30-36.
9. Ho, H.T., Woods, K.L., Bronson, J.J., De Boeck, H., Martin, J.C., and Hitchcock, M.J. (1992). Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Mol. Pharmacol. 41, 197-202
10. Kirsch, L.S., Arevalo, J.F., De Clercq, E., Chavez de la Paz, E., Munguia, D., Garcia, R. and Freeman, W.R. (1995) Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 119, 466-476.
11. Lalezari, J., Stagg, R., Kuppermann, B., Kramer, F., Holland, G., Ives, D., Youle, M., Robinson, M., Northfelt, D. and Eron, J. (1995a) A phase II/III randomized study of immediate versus deferred intravenous (IV) cidofovir (CDV, HPMPC) for the treatment of peripheral CMV retinitis (CMV-R) in patients with AIDS. Natl. Conf. Hum. Retroviruses Relat. Infect. (2nd), p 170.
12. Lalezari, J.P., Drew, W.L., Glutzer, E., James, C., Miner, D., Flaherty, J., Fisher, P.E., Cundy, K., Hannigan, J. and Martin, J.C. (1995b) (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J. Infect. Dis. 171, 788-796.
13. Mayers, D.L., Japour, A.J., Arduino, J.M., Hammer, S.M., Reichman, R., Wagner, K.F., Chung, R., Lane, J., Crumpacker, C.S. and McLeod, G.X. (1994) Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group. Antimicrob. Agents Chemother. 38, 307-314.
14. Mendel, D.B., Cherrington, J.M., Barkhimer, D.B., AlLen, S.J. and Chen, M.S. (1994) Differential uptake and metabolism of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in four cell lines and kinetic analysis of HPM-PCpp with HIV reverse transcriptase (HIV-RT). Program. Abstr. Intersci. Conf. Antimicrob. Agents Chemother.
15. PaLu, G., Stefanelli, S., Rassu, M., Parolin, C., Balzarini, J. and De Clercq, E. (1991) Cellular uptake of phosphonylmethoxyalkylpurine derivatives. Antiviral Res. 16, 115-119.
16. Phillips, D.M., Zacharopoulos, V.R., Tan, X. and Pearce-Pratt, R. (1994) Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia? Trends. Microbiol. 2, 454-458.
17. Srinivas, R.V., Birkedal, B., Owens, R.J., Anantharamaiah, G.M., Segrest, J.P., and Compans, R.W. (1990). Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs. Virology 176, 48-57.
18. Srinivas, R.V., Robbins, B.L., Connelly, M.C., Gong, Y.F., Bischofberger, N. and Fridland, A. (1993) Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Antimicrob. Agents Chemother. 37, 2247-2250.
19. Xiong, X., Smith, J.L. and Chen, M.S. (1995) Interaction of cidofovir diphosphate with the DNA polymerase encoded by human cytomegalovirus. Natl. Conf. Hum. Retroviruses Relat. Infect. (2nd), p 107.